MabionCD20 Compared to MabThera in Lymphoma Patients

Clinical trial NCT02617485 · COMPLETED

Trial details

NCT number: NCT02617485
Sponsor: Mabion SA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2015-12-01
Primary completion: 2017-08-01
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.